Cart

Who Profits From Uncritical Acceptance of Biased Estimates of Vaccine Efficacy and Safety?

CopyRight

Correspondence should be sent to Lucija Tomljenovic, PhD, Neural Dynamics Research Group, Department of Ophthalmology and Visual Sciences, University of British Columbia, 828 W. 10th Ave., Vancouver, BC, V5Z 1L8, Canada (e-mail: ). Reprints can be ordered at http://www.ajph.org by clicking the “Reprints” link.

 Note. The authors have no relationship with Merck & Co., Inc. All views expressed herein are solely our own.

Contributors

Both authors wrote and revised the letter.

https://doi.org/10.2105/AJPH.2012.300837
Accepted: April 02, 2012
Published Online: July 19, 2012
"Who Profits From Uncritical Acceptance of Biased Estimates of Vaccine Efficacy and Safety?." , 102(9), pp. e13–e14
Affiliations
  • At the time of the writing, Lucija Tomljenovic and Christopher A. Shaw were with the Neural Dynamics Research Group, University of British Columbia, Vancouver, Canada.

Related

No related items

TOOLS

Downloaded 10 times

SHARE

ARTICLE CITATION

Lucija Tomljenovic, PhD, and Christopher A. Shaw, PhDAt the time of the writing, Lucija Tomljenovic and Christopher A. Shaw were with the Neural Dynamics Research Group, University of British Columbia, Vancouver, Canada. “Who Profits From Uncritical Acceptance of Biased Estimates of Vaccine Efficacy and Safety?”, American Journal of Public Health 102, no. 9 (September 1, 2012): pp. e13-e14.

https://doi.org/10.2105/AJPH.2012.300837

PMID: 22813421